News Jounce elopes with Concentra, leaving Redx at the altar A $425 million proposed marriage between Redx Pharma of the UK and Jounce Ther
News AZ, Ionis build case for amyloidosis drug eplontersen Long-term data in ATTR polyneuropathy boost drug's credentials ahead of December FDA decision.
News Novartis preps key early breast cancer filing for Kisqali NATALEE trial readout sets up Kisqali as rival to Lilly's Verzenio as adjuvant treatment.
News FDA eyes shake-up of swift approval pathway in cancer Regulator wants more use of randomised controlled trials rather than open-label studies.
News Former Seagen CEO Siegall pops up at new biotech Siegall resigned from Seagen last year amid claims of domestic abuse, though was not charged.
News Sanofi, Regeneron’s wager on Dupixent in COPD pays off Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
